UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007796
Receipt number R000009186
Scientific Title Short term MET effects on insulin resistance in type 2 diabetes mellitus.
Date of disclosure of the study information 2012/04/20
Last modified on 2018/04/25 09:15:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Short term MET effects on insulin resistance in type 2 diabetes mellitus.

Acronym

Short term MET effects on insulin resistance in T2DM

Scientific Title

Short term MET effects on insulin resistance in type 2 diabetes mellitus.

Scientific Title:Acronym

Short term MET effects on insulin resistance in T2DM

Region

Japan


Condition

Condition

Type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the acute effect of MET on insulin resistance measured by hyperinsulinemic euglycemic glucose clamp.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

glucose infusion rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

MET treatment (1.4 V/cm, 0.1ms, 55 pps, 42 degrees) for 60min.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

65 years-old >

Gender

Male

Key inclusion criteria

Type 2 diabetes mellitus (T2DM)
i)Abdominal obesity, given as waist circumference
greater than 85 cm
ii)HbA1c more than 6.9%, less than 10.5% (NGSP)

Key exclusion criteria

i) Past history or current medication of myocardial infarction, angina, apoplexy and arteriosclerosis obliterans.
ii)Severe wound, infections, pre- or post-operation.
iii)Severe liver dysfunction (GOT and/or GPT: greater than 100U).
iv)Chronic heart failure, familial dyslipidemia.
v)Severe diabetic complications.
vi)Pacemaker carrier.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiichi Araki

Organization

Kumamoto University, Faculty of Life Sciences.

Division name

Metabolic Medicine

Zip code


Address

1-1-1 Honjo, Kumamoto

TEL

096-373-5169

Email

earaki@gpo.kumamoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tatsuya Kondo

Organization

Kumamoto University, Faculty of Life Sciences.

Division name

Metabolic Medicine

Zip code


Address

1-1-1 Honjo, Chuo-ku, Kumamoto

TEL

096-373-5169

Homepage URL


Email

t-kondo@gpo.kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University, Faculty of Life Sciences, Metabolic Medicine

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University, Faculty of Life Sciences, Metabolic Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 04 Month 17 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 05 Month 01 Day

Date analysis concluded

2013 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 04 Month 20 Day

Last modified on

2018 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009186


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name